HealthiVibe Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • HealthiVibe's estimated annual revenue is currently $7.8M per year.(i)
  • HealthiVibe's estimated revenue per employee is $201,000

Employee Data

  • HealthiVibe has 39 Employees.(i)
  • HealthiVibe grew their employee count by -39% last year.

HealthiVibe's People

NameTitleEmail/Phone
1
Senior Director, Patient ExperienceReveal Email/Phone
2
Senior Director, Patient Centric SolutionsReveal Email/Phone
3
Director OperationsReveal Email/Phone
4
Senior Project ManagerReveal Email/Phone
5
Information Technology Project ManagerReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
IT Project ManagerReveal Email/Phone
8
Project ManagerReveal Email/Phone
9
Senior Human Resources ManagerReveal Email/Phone
10
Manager, Client SolutionsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7925%$210MN/A
#2
$30.2M182N/AN/AN/A
#3
$6.6M336%N/AN/A
#4
$7.8M39-39%N/AN/A
#5
$4.8M244%N/AN/A
#6
$12.5M627%N/AN/A
#7
$22.1M1107%N/AN/A
#8
$11.7M58-9%N/AN/A
#9
$5.8M29-12%N/AN/A
#10
$42.4M211N/AN/AN/A
Add Company

What Is HealthiVibe?

HealthiVibe offers a systematic, evidence-based process for companies to engage the patient at every stage of the pharmaceutical project lifecycle: from clinical trial design through post-approval activities and research. We offer full-service patient initiatives, with a focus on patient insights and communication, to help biopharmaceutical companies create more patient-centered programs.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.8M

Revenue (est)

-39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HealthiVibe News

2022-03-22 - How Janssen/HealthiVibe's Program Found The Right ...

How Janssen/HealthiVibe's Program Found The Right Messages To Improve Trial Diversity. 10 Mar 2022. Analysis. Alaric DeArment biotechvisigoth...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3911%N/A
#2
$3.5M393%N/A
#3
$6.6M390%N/A
#4
$8.4M3918%N/A
#5
$3.5M39-2%N/A